Patricia Morris
Nurse Practitioner · Nashville, TNNPI 1306930524
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Stemline Therapeutics Inc. accounts for 98.0% of it on its own, with 17 other manufacturers making up the rest. Among nurse practitioner clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $334.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stemline Therapeutics Inc.$52K
- Novartis$281
- Daiichi Sankyo Inc.$145
- AstraZeneca$110
- Merck$79
- Gilead$67
- plus $360 from 12 others
What the payments were for
- Speaking & faculty fees$31,70959%
- Travel & lodging$17,52933%
- Food & beverage$4,2028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stemline Therapeutics Inc. | 116 | $52,398 |
| Novartis | 10 | $281 |
| Daiichi Sankyo Inc. | 6 | $145 |
| AstraZeneca | 5 | $110 |
| Merck | 3 | $79 |
| Gilead | 3 | $67 |
| Eisai Inc. | 3 | $57 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $46 |
| Johnson & Johnson | 2 | $38 |
| Pfizer | 2 | $36 |
| Pharmaessentia USA Corporation | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Deciphera Pharmaceuticals Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $21 |
| AbbVie | 1 | $20 |
| Coherus Oncology, Inc. | 1 | $19 |
| Accord Healthcare, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orserdu$50,969
How this compares
$53,441 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 12 | $184,322 |
| Exemestane | 29 | $7,802 |
| Letrozole | 96 | $1,278 |
| Tamoxifen Citrate | 24 | $402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCVerzenio | $22 | $184,32212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Nashville
- Susan UtleyNashville$194K
- Brooke FaughtNashville$87K
- Lauren WelchNashville$71K
- Molly MueckeNashville$30K
- Cherish HoltNashville$20K
- Virginia BradshawNashville$17K
- Bettina EnghNashville$17K
- Megan HuningNashville$12K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.